An Integrated Architecture for Colorectal Polyp Segmentation: The µ-Net Framework with Explainable AI.
Colorectal cancer (CRC) is the second-deadliest cancer globally, with an estimated 52,900 additional deaths expected in the United States by 2025.
APA
Emon MH, Mondal PK, et al. (2025). An Integrated Architecture for Colorectal Polyp Segmentation: The µ-Net Framework with Explainable AI.. Diagnostics (Basel, Switzerland), 15(22). https://doi.org/10.3390/diagnostics15222890
MLA
Emon MH, et al.. "An Integrated Architecture for Colorectal Polyp Segmentation: The µ-Net Framework with Explainable AI.." Diagnostics (Basel, Switzerland), vol. 15, no. 22, 2025.
PMID
41300913
Abstract
Colorectal cancer (CRC) is the second-deadliest cancer globally, with an estimated 52,900 additional deaths expected in the United States by 2025. Early detection through colonoscopy significantly reduces CRC mortality by enabling the removal of pre-cancerous polyps. However, manual visual inspection of colonoscopy images is time-consuming, tedious, and prone to human error. This study aims to develop an automated and reliable polyp segmentation and classification method to improve CRC screening. We propose a novel deep learning architecture called µ-Net for accurate polyp segmentation in colonoscopy images. The model was trained and evaluated using the Kvasir-SEG dataset. To ensure transparency and reliability, we incorporated Explainable AI (XAI) techniques, including saliency maps and Grad-CAM, to highlight regions of interest and interpret the model's decision-making process. The µ-Net model achieved a Dice coefficient of 94.02%, outperforming other available segmentation models in accuracy, indicating its strong potential for clinical deployment. Integrating XAI provided meaningful visual explanations, enhancing trust in model predictions. The proposed µ-Net framework significantly improves the Precision and efficiency of automated polyp screening. Its ability to segment, classify, and interpret colonoscopy images enables early detection and supports clinical decision-making. This comprehensive approach offers a valuable tool for CRC prevention, ultimately contributing to better patient outcomes.